Formulation and evaluation of transdermal delivery system of an anti-hypertensive drug

D. S. Goswami; N. Uppal

Authors

D. S. Goswami Department of Pharmaceutics, S.D. College of Pharmacy, Barnala, Punjab-148101
N. Uppal Department of Pharmaceutics, S.D. College of Pharmacy, Barnala, Punjab-148101

Keywords:

Captopril, transdermal therapeutic system, ethyl cellulose (EC), polyvinyl

Abstract

The present study was aims to formulate and evaluate transdermal drug delivery for sustained release of an anti-hypertensive drug Captopril, it is considered as drug of choice in anti hypertensive therapy and is reported for potential administration through transdermal route. The investigation was carried out to study the effect of different proportion of ethyl cellulose and PVP a hydrophobic and hydrophilic polymer respectively. Transdermal patches were prepared using different combination of the two polymers by solvent evaporation technique. Polyvinyl alcohol was used to prepare the backing membrane and dibutyl phthalate as a plasticizer. Several Physicochemical parameter like moisture content, moisture loss, thickness, film folding endurance, tensile strength, flatness were studied. For all the formulations, in vitro drug release was studied using modified diffusion cell. Formulations with highest proportion of polyvinyl pyrolidone shows faster release whereas increasing proportion of ethyl cellulose produces a prolonged regimen of sustained drug delivery through transdermal route for a period of 24 hrs.

Downloads

Download data is not yet available.

References

Arunachalam A, Karthikeyan M, Kumar VD, Prathap M and Sethuraman S. Transdermal drug delivery system: A review. Curr Pharm Res. 2010; 1(1): 70-81.

Selvam PR, Kumar SA and Kumar ST. Transdermal drug delivery systems for antihypertensive drugs - A review. Int J Pharm Biomed Res. 2010; 1(1): 1-8.

Tripathi KD, Antihypertensive agents. In: Essentials of medical pharmacology. Edn:6th. NewDelhi: Jaypee brothers; 2008. p. 445-450.

Sharan G, Dey KB, Das S and Kumar VS. Effect of various permeation enhancers on propranolol hydrochloride formulated patches. Int J Pharmacy Pharm Sci. 2010; 2(2): 21-31.

Gupta JRD, Irchhiaya R, Garud N, Tripathi P and Dubey P. Formulation and evaluation of transdermal patches of glibenclamide. Int J Pharm Sci Drug Res. 2009; 1(1): 46-50.

Verma PP and Iyer SS. Transdermal delivery of propanolol using mixed grade of eudragit: Design and in vitro and in vivo evaluation. Drug Dev Ind Pharm. 2000; 26: 471‐476.

Devi VK, Saisivam S and Maria GR. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev Ind Pharm. 2003; 29: 495‐503.

Rao V, Mamatha T, Mukkanti K and Ramesh. Transdermal drug delivery system for atomoxetine hydrochloride in vitro and ex vivo evaluation. Curr Trends Biotech Pharmacy. 2009; 3(2): 188-96.

Dey BK, Nath LK, Mohanti B and Bhowmik BB. Development and evaluation of propranolol hydrochloride transdermal patches by using hydrophilic and hydrophobic polymer. Ind J Pharm Edu Res. 2007; 41(4): 388-393.

Sonjoy M and Ratan GN. Formulation and evaluation of carvedilol transdermal patches. Int Res J Pharmacy. 2011; 2(1): 237-248